Biotech Values

[DewDiligence]

Study demonstrates efficacy of ABT’s MitraClip valve to treat mitral regurgitation:

http://www.reuters.com/article/idCNN1417954520100314

This is the product ABT acquired from Evalve six months ago for $300 plus milestones (#msg-41374735). It is already approved in the EU and a PMA application is pending at the FDA.